These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 34239351)
41. KLF15-activated MARCH2 boosts cell proliferation and epithelial-mesenchymal transition and presents diagnostic significance for hepatocellular carcinoma. Ni D; Qi Z; Wang Y; Man Y; Pang J; Tang W; Chen J; Li J; Li G Exp Cell Res; 2024 Jul; 440(1):114117. PubMed ID: 38848952 [TBL] [Abstract][Full Text] [Related]
42. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006 [TBL] [Abstract][Full Text] [Related]
43. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A. Zhou C; Chen Z; Peng C; Chen C; Li H Cancer Biother Radiopharm; 2021 Mar; 36(2):211-219. PubMed ID: 32391716 [No Abstract] [Full Text] [Related]
44. Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622. Zou H; Xu X; Luo L; Zhang Y; Luo L; Yao Y; Xiang G; Huang X; Wang G Cell Cycle; 2019 Oct; 18(19):2398-2413. PubMed ID: 31095447 [TBL] [Abstract][Full Text] [Related]
45. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S; Wang L; Yao B; Liu Q; Guo C Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165 [TBL] [Abstract][Full Text] [Related]
46. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging. Li Y; Chen G; Yan Y; Fan Q Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158 [TBL] [Abstract][Full Text] [Related]
47. Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway. Yan K; Xu X; Wu T; Li J; Cao G; Li Y; Ji Z Biochem Biophys Res Commun; 2019 Dec; 520(2):486-491. PubMed ID: 31606203 [TBL] [Abstract][Full Text] [Related]
48. MiR-26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β-catenin signaling. Hu X; Wang R; Ren Z; Liu X; Gu J; Cui G; Li Q Cancer Med; 2019 Dec; 8(17):7359-7371. PubMed ID: 31637871 [TBL] [Abstract][Full Text] [Related]
49. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway. Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132 [TBL] [Abstract][Full Text] [Related]
50. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1. Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654 [TBL] [Abstract][Full Text] [Related]
51. Hepatocellular carcinoma cell-derived extracellular vesicles encapsulated microRNA-584-5p facilitates angiogenesis through PCK1-mediated nuclear factor E2-related factor 2 signaling pathway. Shao Z; Pan Q; Zhang Y Int J Biochem Cell Biol; 2020 Aug; 125():105789. PubMed ID: 32522621 [TBL] [Abstract][Full Text] [Related]
52. Long noncoding RNA AC092171.4 promotes hepatocellular carcinoma progression by sponging microRNA-1271 and upregulating GRB2. Sun C; Huang S; Hou Y; Li Z; Xia D; Zhang L; Zhang Y; Cai Y; Wang Z; Zhou Q; He X; Wu L Aging (Albany NY); 2020 Jul; 12(14):14141-14156. PubMed ID: 32692718 [TBL] [Abstract][Full Text] [Related]
53. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p. Liu H; Xue L; Song C; Liu F; Jiang T; Yang X Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881 [TBL] [Abstract][Full Text] [Related]
54. Long noncoding RNA LINC02580 suppresses the invasion-metastasis cascade in hepatocellular carcinoma by targeting SRSF1. Xu L; Wang Z; Yin C; Pan F; Shi T; Tian Y Biochem Biophys Res Commun; 2020 Dec; 533(4):685-691. PubMed ID: 33168192 [TBL] [Abstract][Full Text] [Related]
55. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development. Zhang N; Chen X Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159 [TBL] [Abstract][Full Text] [Related]
56. BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway. Xiao S; Chen J; Wei Y; Song W Eur J Med Res; 2024 May; 29(1):302. PubMed ID: 38811952 [TBL] [Abstract][Full Text] [Related]
57. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
58. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523 [TBL] [Abstract][Full Text] [Related]
59. PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488. Wang D; Wang L; Zhang Y; Yan Z; Liu L; Chen G Biomed Pharmacother; 2019 Mar; 111():588-595. PubMed ID: 30605882 [TBL] [Abstract][Full Text] [Related]
60. LINC01123 acts as an oncogenic driver in lung adenocarcinoma by regulating the miR-4766-5p/PYCR1 axis. Wang H; He D Histol Histopathol; 2023 Dec; 38(12):1475-1486. PubMed ID: 36994814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]